ConductScience.org, home

Paper8494366

Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect.

Kadurugamuwa JL and 2 others. Antimicrob Agents Chemother, 1993. Cited by 90 papers, by iCite.

Cite this record

ConductScience Library. Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect. Papers, record 8494366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8494366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
90
iCite
Relative citation ratio, by iCite
2.91
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kadurugamuwa JLJ L
2Lam JSJ S
3Beveridge TJT J

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GentamicinsMajor topic
LipopolysaccharidesMajor topic
Pseudomonas aeruginosaMajor topic
Blotting, Western
Cell Membrane
Electrophoresis, Polyacrylamide Gel
Muramidase
Silver Staining

Source PubMed

Download CSV of topics

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14313132Role of divalent cations in the action of polymyxin B and EDTA on Pseudomonas aeruginosa.J Gen Microbiol1969https://conductscience.org/library/papers/4313132PubMed
214450178Kinetics of loss of vibility of Escherichia coli exposed to streptomycin.J Bacteriol1962https://conductscience.org/library/papers/14450178PubMed
3820248Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/820248PubMed
497259Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro.J Antimicrob Chemother1978https://conductscience.org/library/papers/97259PubMed
5110433The extraction and analysis of lipopolysaccharides from Pseudomonas aeruginosa strain PAO, and three rough mutants.Can J Microbiol1979https://conductscience.org/library/papers/110433PubMed
6118160Outer membrane of Pseudomonas aeruginosa: heat- 2-mercaptoethanol-modifiable proteins.J Bacteriol1979https://conductscience.org/library/papers/118160PubMed
77446125Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre.Acta Pathol Microbiol Scand B1980https://conductscience.org/library/papers/7446125PubMed
86268456Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium.FEBS Lett1981https://conductscience.org/library/papers/6268456PubMed
96176137A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.Anal Biochem1982https://conductscience.org/library/papers/6176137PubMed
106803667Chemical and chromatographic analysis of lipopolysaccharide from an antibiotic-supersusceptible mutant of Pseudomonas aeruginosa.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6803667PubMed
116293694Adaptive resistance to polymyxin in Pseudomonas aeruginosa due to an outer membrane impermeability mechanism.Can J Microbiol1982https://conductscience.org/library/papers/6293694PubMed
126187729Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.J Bacteriol1983https://conductscience.org/library/papers/6187729PubMed
136302204Alteration of susceptibility to EDTA, polymyxin B and gentamicin in Pseudomonas aeruginosa by divalent cation regulation of outer membrane protein H1.J Gen Microbiol1983https://conductscience.org/library/papers/6302204PubMed
146405665The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis.Am Rev Respir Dis1983https://conductscience.org/library/papers/6405665PubMed
156351731Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6351731PubMed
166413410Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.Infect Immun1983https://conductscience.org/library/papers/6413410PubMed
176197737Composition and structure of lipopolysaccharides from Pseudomonas aeruginosa.Rev Infect Dis1983https://conductscience.org/library/papers/6197737PubMed
186207771Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6207771PubMed
196436396Biphasic, concentration-dependent and rate-limited, concentration-independent bacterial killing by an aminoglycoside antibiotic.J Infect Dis1984https://conductscience.org/library/papers/6436396PubMed
206093683Alterations in outer membrane permeability.Annu Rev Microbiol1984https://conductscience.org/library/papers/6093683PubMed

See all 46 referencesDownload CSV of references

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.

PMIDTitleJournalYearIn PapersSource
41614127Glutamate potentiates susceptibility of P. aeruginosa clinical isolates to gentamycin: a new adjuvant hope for an old antibiotic.Front Microbiol2025https://conductscience.org/library/papers/41614127PubMed
38954678The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures.PLoS Biol2024https://conductscience.org/library/papers/38954678PubMed
38736943Increased antibiotic resistance of Pseudomonas aeruginosa isolates from chronic rhinosinusitis patients grown in anaerobic conditions.Laryngoscope Investig Otolaryngol2024https://conductscience.org/library/papers/38736943PubMed
38501368In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece.J Antimicrob Chemother2024https://conductscience.org/library/papers/38501368PubMed
37533213Illuminating the oral microbiome: cellular microbiology.FEMS Microbiol Rev2023https://conductscience.org/library/papers/37533213PubMed
37223363Antibiotic tolerance in environmentally stressed Bacillus subtilis: physical barriers and induction of a viable but nonculturable state.Microlife2022https://conductscience.org/library/papers/37223363PubMed
35341941Identifying targets to prevent aminoglycoside ototoxicity.Mol Cell Neurosci2022https://conductscience.org/library/papers/35341941PubMed
34827367Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa.Antibiotics (Basel)2021https://conductscience.org/library/papers/34827367PubMed
34439073Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring blaNDM-1 and blaNDM-5.Antibiotics (Basel)2021https://conductscience.org/library/papers/34439073PubMed
32457248Parallel Evolution of Tobramycin Resistance across Species and Environments.mBio2020https://conductscience.org/library/papers/32457248PubMed
31861540The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology.Pathogens2019https://conductscience.org/library/papers/31861540PubMed
31781056Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms.Front Microbiol2019https://conductscience.org/library/papers/31781056PubMed
31540233Silk-Based Therapeutics Targeting Pseudomonas aeruginosa.J Funct Biomater2019https://conductscience.org/library/papers/31540233PubMed
30837659Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins.Sci Rep2019https://conductscience.org/library/papers/30837659PubMed
30688634Agmatine accumulation by Pseudomonas aeruginosa clinical isolates confers antibiotic tolerance and dampens host inflammation.J Med Microbiol2019https://conductscience.org/library/papers/30688634PubMed
29463528
Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling.
Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29463528PubMed
29339388Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29339388PubMed
29039211Synergistic effects of heat and antibiotics on Pseudomonas aeruginosa biofilms.Biofouling2017https://conductscience.org/library/papers/29039211PubMed
28993331
Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes.
Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28993331PubMed
28893782Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28893782PubMed

See all 56 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8494366

GET https://conductscience.org/api/papers/v1/8494366/references?page=2